SPI Digital Health: Google Cloud Gets a Sense of Huma

It was a story of yet another company struggling with spiralling operating expenses as it emerged at the end of last month that UK-based RPM vendor Huma Therapeutics was laying off around 10% of its 500-strong global workforce.  

An internal staff e-mail, reported by the media, blamed the redundancies on a slowdown in revenue growth and a challenging fund-raising climate. For many RPM vendors competing in a highly fragmented, cut-throat market, revenue growth doesn’t necessarily mean profit. Cost cutting measures, including layoffs, are a painful reality for some to stay afloat in the post-COVID world.